The TREAT project: decision support and prediction using causal probabilistic networks.

[1]  Steen Andreassen,et al.  Prediction of specific pathogens in patients with sepsis: evaluation of TREAT, a computerized decision support system. , 2007, The Journal of antimicrobial chemotherapy.

[2]  Cathy A Petti,et al.  Medical Microbiology: Detection and Identification of Microorganisms by Gene Amplification and Sequencing , 2007 .

[3]  J. Kluytmans,et al.  Appropriateness of Antimicrobial Therapy Measured by Repeated Prevalence Surveys , 2007, Antimicrobial Agents and Chemotherapy.

[4]  Jessina C. McGregor,et al.  Clinical Prediction Tool To Identify Patients with Pseudomonas aeruginosa Respiratory Tract Infections at Greatest Risk for Multidrug Resistance , 2006, Antimicrobial Agents and Chemotherapy.

[5]  M. Larocco,et al.  Comparison of Risk Factors for Candidemia Versus Bacteremia in Hospitalized Patients , 2006, Infection.

[6]  Steen Andreassen,et al.  Improving empirical antibiotic treatment using TREAT, a computerized decision support system: cluster randomized trial. , 2006, The Journal of antimicrobial chemotherapy.

[7]  S. Andreassen,et al.  Benefit of appropriate empirical antibiotic treatment: thirty-day mortality and duration of hospital stay. , 2006, The American journal of medicine.

[8]  Steen Andreassen,et al.  Prediction of bacteremia using TREAT, a computerized decision-support system. , 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[9]  E. Tacconelli.  New strategies to identify patients harbouring antibiotic-resistant bacteria at hospital admission. , 2006, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[10]  L. Leibovici,et al.  Characteristics of candidaemia with Candida-albicans compared with non-albicans Candida species and predictors of mortality. , 2005, The Journal of hospital infection.

[11]  M. Oh,et al.  Risk factors for antimicrobial resistance and influence of resistance on mortality in patients with bloodstream infection caused by Pseudomonas aeruginosa. , 2005, Microbial drug resistance.

[12]  Sung-Han Kim,et al.  Bloodstream Infections Caused by Antibiotic-Resistant Gram-Negative Bacilli: Risk Factors for Mortality and Impact of Inappropriate Initial Antimicrobial Therapy on Outcome , 2004, Antimicrobial Agents and Chemotherapy.

[13]  Laura Maruster,et al.  ARTIFICIAL INTELLIGENCE IN MEDICINE, PROCEEDINGS , 2005 .

[14]  Steen Andreassen,et al.  A Probabilistic Network for Fusion of Data and Knowledge in Clinical Microbiology , 2005 .

[15]  Leonard Leibovici,et al.  β lactam monotherapy versus β lactam-aminoglycoside combination therapy for sepsis in immunocompetent patients: systematic review and meta-analysis of randomised trials , 2004, BMJ : British Medical Journal.

[16]  J. Garnacho-Montero,et al.  Impact of adequate empirical antibiotic therapy on the outcome of patients admitted to the intensive care unit with sepsis* , 2003, Critical care medicine.

[17]  Stephan Harbarth,et al.  Inappropriate initial antimicrobial therapy and its effect on survival in a clinical trial of immunomodulating therapy for severe sepsis. , 2003, The American journal of medicine.

[18]  Steen Andreassen,et al.  Hierarchical Dirichlét Learning - Filling in the Thin Spots in a Database , 2003, AIME.

[19]  L. Leibovici,et al.  β lactam monotherapy versus β lactam-aminoglycoside combination therapy for fever with neutropenia: systematic review and meta-analysis , 2003, BMJ : British Medical Journal.

[20]  J. Rello,et al.  Community-acquired bloodstream infection in critically ill adult patients: impact of shock and inappropriate antibiotic therapy on survival. , 2003, Chest.

[21]  K. Mølbak,et al.  Survival of Patients with Bacteraemia in Relation to Initial Empirical Antimicrobial Treatment , 2002, Scandinavian journal of infectious diseases.

[22]  K. Soares-Weiser,et al.  Beta lactam monotherapy versus beta lactam‐aminoglycoside combination therapy for treating sepsis , 2001 .

[23]  G Sherman,et al.  The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting. , 2000, Chest.

[24]  Steen Andreassen,et al.  A Causal Probabilistic Network for Optimal Treatment of Bacterial Infections , 2000, IEEE Trans. Knowl. Data Eng..

[25]  L. Leibovici,et al.  Bacteraemia caused by hospital-type micro-organisms during hospital stay. , 2000, The Journal of hospital infection.

[26]  Leibovici,et al.  The benefit of appropriate empirical antibiotic treatment in patients with bloodstream infection , 1998, Journal of internal medicine.

[27]  J. Burke.  Antibiotic resistance--squeezing the balloon? , 1998, JAMA.

[28]  D. Horn,et al.  Class restriction of cephalosporin use to control total cephalosporin resistance in nosocomial Klebsiella. , 1998, JAMA.

[29]  Leonard Leibovici,et al.  Risk factors and a clinical index for diagnosis of Pseudomonas aeruginosa bacteremia. , 1995, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[30]  I. Phillips,et al.  Clinical index to predict bacteraemia caused by staphylococci , 1993, Journal of internal medicine.

[31]  L. Leibovici,et al.  Toward improved empiric management of moderate to severe urinary tract infections. , 1992, Archives of internal medicine.

[32]  L. Leibovici,et al.  Predictive index for optimizing empiric treatment of gram-negative bacteremia. , 1991, The Journal of infectious diseases.

[33]  D. Maki,et al.  A study of antimicrobial misuse in a university hospital. , 1978, The American journal of the medical sciences.

[34]  John M Hartwick.  Exploitation of Many Deposits of an Exhaustible Resource , 1978 .